| 2026 Financial Year |
| 15 Sep 2025 |
New Chair and MD Appointments
|
View PDF
|
| 15 Sep 2025 |
Chair’s Resignation
|
View PDF
|
| 12 Sep 2025 |
FY25 Appendix 4G and Corporate Governance Statement
|
View PDF
|
| 12 Sep 2025 |
FY25 Annual Report
|
View PDF
|
| 29 Aug 2025 |
FY25 Results Presentation
|
View PDF
|
| 29 Aug 2025 |
FY25 Results
|
View PDF
|
| 29 Aug 2025 |
FY25 Appendix 4E Preliminary Final Report
|
View PDF
|
| 27 Aug 2025 |
FY25 Results Presentation Notification
|
View PDF
|
| 26 Aug 2025 |
Notification of cessation of securities – BUB
|
View PDF
|
| 28 Jul 2025 |
CEO Appointment Joe Coote
|
View PDF
|
| 28 Jul 2025 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
View PDF
|
| 2025 Financial Year |
| 16 Jun 2025 |
BUBS SUBMITS CLINICAL TRIAL DATA TO US FDA
|
View PDF
|
| 29 Apr 2025 |
Alpha Group Legal Dispute
|
View PDF
|
| 28 Apr 2025 |
Q3 FY25 Quarterly Activities Report and Appendix 4C Cashflow Statement
|
View PDF
|
| 28 Feb 2025 |
Bubs Australia – Half Year Results Presentation
|
View PDF
|
| 28 Feb 2025 |
Bubs Australia – Half Year Results Commentary
|
View PDF
|
| 28 Feb 2025 |
Bubs Australia – Half Year Report and Appendix 4D
|
View PDF
|
| 25 Feb 2025 |
1H FY25 Results Announcement Date and Webcast Notification
|
View PDF
|
| 14 Oct 2024 |
Appendix 4G
|
View PDF
|
| 14 Oct 2024 |
Corporate Governance Statement
|
View PDF
|
| 14 Oct 2024 |
Annual Report to shareholders
|
View PDF
|
| 28 Aug 2024 |
Bubs FY24 Results Presentation
|
View PDF
|
| 28 Aug 2024 |
Bubs FY24 Results
|
View PDF
|
| 28 Aug 2024 |
Bubs – FY24 Appendix 4E Preliminary Final Report
|
View PDF
|
| 27 Aug 2024 |
FY24 Results Presentation Webinar Notification
|
View PDF
|
| 29 Jul 2024 |
Bubs Q4 FY24 Quarterly Activity and Cashflow Statement
|
View PDF
|